Somatrogon
id:
somatrogon-297-785258
title:
Somatrogon
text:
Somatrogon, sold under the brand name Ngenla, is a medication for the treatment of growth hormone deficiency. Somatrogon is a glycosylated protein constructed from human growth hormone and a small part of human chorionic gonadotropin which is appended to both the N-terminal and C-terminal. Somatrogon is a human growth hormone analog. The most common side effects include reactions at the site of injection, headache, and fever. Somatrogon was approved for medical use in Australia in November 2021,
brand slug:
wiki
category slug:
encyclopedia
description:
Chemical compound
original url:
https://en.wikipedia.org/wiki/Somatrogon
date created:
date modified:
2024-04-14T07:30:18Z
main entity:
{"identifier":"Q110220159","url":"https://www.wikidata.org/entity/Q110220159"}
image:
fields total:
13
integrity:
14